Literature DB >> 26191203

The roles of APOBEC3B in gastric cancer.

Jian Zhang1, Wei Wei1, Hui-Cheng Jin1, Rong-Chao Ying1, A-Kao Zhu1, Fang-Jie Zhang1.   

Abstract

Gastric cancer was the third cause of death in China. In this study, we found that the APOBEC3 (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3) expression was higher in gastric cancer tissues than that in normal tissues and confirmed APOBEC3B expression was correlated with the unfavorable prognosis of the patients with gastric cancer. Furthermore, APOBEC3B expression was associated with gender, tumor size, histological grade, T stage, and TNM staging of the patients with gastric cancer. Down-regulation of APOBEC3B expression in MNK28 cells could enhance the cytotoxicity of PDCD2. No editing took place in PDCD2 positive MKN28 cells with APOBEC3B shRNA. These results indicated that loss of function of PDCD2 may be partly caused by APOBEC3B-induced extensive mutagenesis.

Entities:  

Keywords:  APOBEC3B; Gastric cancer; PDCD2; prognosis; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26191203      PMCID: PMC4503075     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  12 in total

1.  Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM.

Authors:  G C Smith; R B Cary; N D Lakin; B C Hann; S H Teo; D J Chen; S P Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Interleukin 16 expression changes in association with ovarian malignant transformation.

Authors:  Aparna Yellapa; Pincas Bitterman; Sameer Sharma; Alfred S Guirguis; Janice M Bahr; Sanjib Basu; Jacques S Abramowicz; Animesh Barua
Journal:  Am J Obstet Gynecol       Date:  2013-12-28       Impact factor: 8.661

3.  Evidence for APOBEC3B mutagenesis in multiple human cancers.

Authors:  Michael B Burns; Nuri A Temiz; Reuben S Harris
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

4.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

5.  Annual report on status of cancer in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

6.  The role of APOBEC3B in chondrosarcoma.

Authors:  Zhe Jin; Ya-Xin Han; Xiao-Rui Han
Journal:  Oncol Rep       Date:  2014-08-22       Impact factor: 3.906

7.  Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.

Authors:  Atsushi Koito; Terumasa Ikeda
Journal:  Front Microbiol       Date:  2013-02-20       Impact factor: 5.640

Review 8.  The AID/APOBEC family of nucleic acid mutators.

Authors:  Silvestro G Conticello
Journal:  Genome Biol       Date:  2008-06-17       Impact factor: 13.583

9.  DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity.

Authors:  Marijn T M van Jaarsveld; Maikel D Wouters; Antonius W M Boersma; Marcel Smid; Wilfred F J van Ijcken; Ron H J Mathijssen; Jan H J Hoeijmakers; John W M Martens; Steven van Laere; Erik A C Wiemer; Joris Pothof
Journal:  Mol Oncol       Date:  2013-12-31       Impact factor: 6.603

Review 10.  The role of cytidine deaminases on innate immune responses against human viral infections.

Authors:  Valdimara C Vieira; Marcelo A Soares
Journal:  Biomed Res Int       Date:  2013-06-25       Impact factor: 3.411

View more
  13 in total

1.  APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.

Authors:  Keisuke Kosumi; Yoshifumi Baba; Takatsugu Ishimoto; Kazuto Harada; Kenichi Nakamura; Mayuko Ohuchi; Yuki Kiyozumi; Daisuke Izumi; Ryuma Tokunaga; Katsunobu Taki; Takaaki Higashi; Tatsunori Miyata; Hironobu Shigaki; Junji Kurashige; Yukiharu Hiyoshi; Masaaki Iwatsuki; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Eiji Oki; Masayuki Watanabe; Hideo Baba
Journal:  Med Oncol       Date:  2016-02-15       Impact factor: 3.064

2.  PDCD2 and NCoR1 as putative tumor suppressors in gastric gastrointestinal stromal tumors.

Authors:  Wei Wang; Xiao-Wen Song; Xian-Min Bu; Ning Zhang; Cheng-Hai Zhao
Journal:  Cell Oncol (Dordr)       Date:  2015-11-20       Impact factor: 6.730

Review 3.  APOBEC3B, a molecular driver of mutagenesis in human cancers.

Authors:  Jun Zou; Chen Wang; Xiangyi Ma; Edward Wang; Guang Peng
Journal:  Cell Biosci       Date:  2017-05-30       Impact factor: 7.133

4.  Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.

Authors:  Xiao Xiao; Hanjing Yang; Vagan Arutiunian; Yao Fang; Guillaume Besse; Cherie Morimoto; Brett Zirkle; Xiaojiang S Chen
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

5.  B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers.

Authors:  Wen-Cheng Chou; Wei-Ting Chen; Chia-Ni Hsiung; Ling-Yueh Hu; Jyh-Cherng Yu; Huan-Ming Hsu; Chen-Yang Shen
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

6.  Progressive APOBEC3B mRNA expression in distant breast cancer metastases.

Authors:  Anieta M Sieuwerts; Willemijne A M E Schrijver; Simone U Dalm; Vanja de Weerd; Cathy B Moelans; Natalie Ter Hoeve; Paul J van Diest; John W M Martens; Carolien H M van Deurzen
Journal:  PLoS One       Date:  2017-01-31       Impact factor: 3.240

7.  Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system.

Authors:  Fubiao Ni; Hengjie Tang; Cheng Wang; Zixiang Wang; Fangyi Yu; Bicheng Chen; Linxiao Sun
Journal:  Cancer Manag Res       Date:  2019-09-13       Impact factor: 3.989

8.  The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.

Authors:  Milaid Granadillo Rodríguez; Ben Flath; Linda Chelico
Journal:  Open Biol       Date:  2020-12-09       Impact factor: 6.411

9.  APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma.

Authors:  Brandon Leonard; Gabriel J Starrett; Matthew J Maurer; Ann L Oberg; Mieke Van Bockstal; Jo Van Dorpe; Olivier De Wever; Jozien Helleman; Anieta M Sieuwerts; Els M J J Berns; John W M Martens; Brett D Anderson; William L Brown; Kimberly R Kalli; Scott H Kaufmann; Reuben S Harris
Journal:  Clin Cancer Res       Date:  2016-03-25       Impact factor: 12.531

10.  Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study.

Authors:  Shumei Yan; Fan He; Bei Gao; Huini Wu; Mei Li; Liyun Huang; Jianzhong Liang; Qiuliang Wu; Yong Li
Journal:  J Cancer       Date:  2016-03-19       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.